Mendota Financial Group’s Cardinal Health CAH Stock Holding History

Mendota Financial Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1	Closed	-$111	–	499
2024 Q3	$111	Buy	+1	New	+$105	﹤0.01%	877
2023 Q2	–	Sell	-3,041	Closed	-$172K	–	318
2023 Q1	$172K	Buy	3,041 +1,392	+84%	+$105K	0.17%	40
2022 Q4	$127K	Buy	+1,649	New	+$125K	0.16%	71

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Mendota Financial Group's CAH Position: Q4 2024 in Review

Mendota Financial Group sold out of Cardinal Health (CAH) in Q4 2024, closing a stake of 1 share — an estimated $111 sold.

Mendota Financial Group first reported a position in CAH in Q4 2022 and held it in 3 quarters. The position peaked at $172K in Q1 2023. 1,097 funds tracked by Wall St. Rank hold CAH as of Q4 2024.

Mendota Financial Group reported no remaining Cardinal Health position as of Q4 2024 after selling out during the quarter.
Mendota Financial Group sold 1 Cardinal Health share in Q4 2024, an estimated $111.
Mendota Financial Group first reported a position in Cardinal Health in Q4 2022 and held it in 3 quarters.
Mendota Financial Group's Cardinal Health position peaked at $172K in Q1 2023.
1,097 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2024.

Based on Mendota Financial Group's 13F filing for Q4 2024, filed 14 Jan 2025.